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Abstract
An investigation of the electrochemical activity of human white blood cells (WBC) for biofuel cell (BFC) applications
is described. WBCs isolated from whole human blood were suspended in PBS and introduced into the anode
compartment of a proton exchange membrane (PEM) fuel cell. The cathode compartment contained a 50 mM
potassium ferricyanide solution. Average current densities between 0.9 and 1.6 μAc m
-2 and open circuit potentials
(Voc) between 83 and 102 mV were obtained, which were both higher than control values. Cyclic voltammetry was
used to investigate the electrochemical activity of the activated WBCs in an attempt to elucidate the mechanism
of electron transfer between the cells and electrode. Voltammograms were obtained for the WBCs, including
peripheral blood mononuclear cells (PBMCs - a lymphocyte-monocyte mixture isolated on a Ficoll gradient), a B
lymphoblastoid cell line (BLCL), and two leukemia cell lines, namely K562 and Jurkat. An oxidation peak at about
363 mV vs. SCE for the PMA (phorbol ester) activated primary cells, with a notable absence of a reduction peak
was observed. Oxidation peaks were not observed for the BLCL, K562 or Jurkat cell lines. HPLC confirmed the
release of serotonin (5-HT) from the PMA activated primary cells. It is believed that serotonin, among other
biochemical species released by the activated cells, contributes to the observed BFC currents.
Background
Presently, there are few options for supplying power to
implantable medical devices. The ultimate goal of this
preliminary work is to develop an implantable biofuel
cell device that may be used within the physiological
environment for low-power implantable medical device
applications (such as miniature biosensors) [1-3]. A bio-
fuel cell (BFC) is an electrochemical or galvanic device
that couples the oxidation of a biofuel (such as glucose)
at the anode to the reduction of molecular oxygen to
water at the cathode. Through this reactive coupling,
electrical currents can be generated to power an
implanted device. With the movement of electrons
through the circuit from the anode to the cathode
through the device, it is necessary to also have the
simultaneous movement of positive charge between the
two electrodes to satisfy the requirements of a closed
circuit. This positive charge takes the form of protons
that travel from the anode through an electrolyte to the
cathode where water is the final byproduct.
Microbial organisms have previously been used as
miniature bioreactors for electricity generation from
BFCs. The microbes metabolize a substrate (such as glu-
cose or acetate) and subsequently transfer high energy
electrons to the anode of the BFC [4-14]. Electrons
derived from these biofuels are subsequently transferred
to the anode across the plasma membrane of the cells,
while protons are also simultaneously released by the
cells into the extracellular space. In another type of BFC
- referred to here as an enzymatic biofuel cell (EnzBFC)
for differentiation - specific enzymes are immobilized at
the anode and cathode [15-21]. At the anode, glucose
oxidase may be used to oxidize glucose to gluconolac-
tone, while a laccase enzyme or bilirubin oxidase may
be tethered to the cathode surface to reduce oxygen to
water.
Electron transfer between cellular metabolic processes
and electrodes has previously only been observed for
microbes confined to the anode of a biofuel cell (BFC).
Electron mediators, such as neutral red, have been
employed to increase the efficiency of electron transfer
between the microbes and the electrode surface [6].
Other microbes, such as Geobacter, have been shown to
be capable of directly transferring electrons to an
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termed metal-reducing bacteria [11-13]. In this study,
we investigate the feasibility of transducing the bio-
chemical energy of white blood cells into electrical
energy, essentially utilizing these eukaryotic cells as
bioreactors at a biofuel cell anode.
Methods
A. Measurement of open circuit potential and current
from BFC device
This study was approved by the Institutional Review
Board (IRB) for Human Subject Research of the Uni-
versity of Pittsburgh. White blood cells (WBC) were
isolated from 5 healthy adult human subjects using a
red blood cell (RBC) lysis technique (Qiagen, Valencia,
CA). Approximately 10 mL of anticoagulated periph-
eral blood was mixed with three volumes of RBC Lysis
solution and incubated for 10 minutes at room tem-
perature. WBC was recovered by centrifugation at 930
g for 10 minutes at 4°C. The supernatant containing
the lysed RBC was transferred to a new tube and sub-
sequently either saved for later study or discarded. The
remaining WBC pellets were washed multiple times (at
least thrice) in 1 × phosphate buffered saline (PBS)
solution and resuspended in PBS to a final volume of
15 mL.
For specific isolation of peripheral blood mononuclear
cells (PBMC), a Ficoll-Paque™ density gradient was
used. Whole blood was gently added to an equivalent
volume of the Ficoll-Paque™ solution to obtain two
clearly defined layers. After centrifugation at 930 g for 20
minutes, four layers can be discerned - red blood cells at
the bottom, followed by a larger volume of the Ficoll
solution, then a thin layer of white blood cells - the
PBMCs (consisting primarily of B and T lymphocytes
a n dm o n o c y t e s )-a n df i n a l ly a larger volume of blood
plasma. The PBMCs were carefully recovered and washed
twice in PBS (pH 7.4) by centrifugation at 800 g for 15
minutes and were finally resuspended in 15 mL PBS.
Multimeters were used to measure the open-circuit
potential, Voc,a sw e l la st h ep o t e n t i a la c r o s sa1 0 0Ω
resistor, Vr,d u r i n gc u r r e n tf l o w .C u r r e n t ,I( μA), and
current density, J (μAc m
-2), were found using Ohm’s
law. The surface area of the electrodes was taken as the
geometric surface area and not the actual surface area.
Woven carbon fiber electrodes (8 cm
2 geometric surface
area and approx. 0.47 m
2 g
-1 specific surface area) were
used for both the anode and cathode (Figure 1). The
Figure 1 (A) WBC biofuel cell experimental setup; (B) SEM of carbon fiber electrode.
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ment, while the cathode compartment contained a 50
mM potassium ferricyanide (K3[Fe(CN)6]) solution in 1
× PBS (pH 7.4). Anode and cathode were separated by a
proton exchange membrane (Nafion-117, Sigma-Aldrich
Co, St. Louis, MO). WBC activation was achieved with
5n gm L
-1 phorbol-12-myristate-13-acetate (PMA) and
500 ng mL
-1 calcium ionomycin (final concentrations in
s o l u t i o n ,S i g m a - A l d r i c h ,S tL o u i s ,M O ) .P M Aa c t i v a t e s
the protein kinase C (PKC) pathway which is involved
in numerous signal transduction cascades leading to
events such as respiratory burst in macrophages and
aggregation of blood platelets. The components used to
construct the BFC, including the walls, chamber and
carbon fiber electrodes, were purchased from the
National Center of Biotechnology Education, University
of Reading, UK (Figure 1).
B. Cyclic voltammetry
Cyclic voltammetry was performed using the Gamry
Potentiostat, FAS2/Femtostat under control of the Gamry
Framework Software from Gamry Instruments (Warmin-
ster, PA). A three-electrode setup was used, where carbon
fiber and platinum served as the working and counter
electrodes, respectively, while a saturated calomel elec-
trode (SCE) served as the reference. PMA (5 ng mL
-1)a n d
calcium ionomycin (500 ng mL
-1) were used to activate
the white blood cells. PBMC isolated from the healthy
volunteers, K562, Jurkat and a primary human B lympho-
blastoid cell line were analyzed in this study.
Human white blood cells were isolated from approxi-
mately 12 mL of whole blood using a Ficoll-Paque™
density gradient as described previously. Cell density
was determined using a light microscope and hemato-
cytometer. K562, BLCL and Jurkat cell lines were also
cultured over a period of one week in RPMI with 10%
fetal bovine serum (FBS). The cells were isolated from
the culture medium by centrifugation, washed twice
with PBS and finally resuspended in 1 × PBS. Cell den-
sity was determined as described above.
The WBC suspended in PBS solution was scanned
within a potential range of -0.5 V to 1.2 V vs. SCE at a
scan rate of 100 mV s
-1. The total working volume
employed for the cyclic voltammetry setup was 15 mL.
The white blood cells were activated by addition of 1 μL
each of phorbol-12-myristate-13-acetate (PMA) and
ionomycin per 1 mL of the total working volume to
achieve final concentrations of 5 ng mL
-1 and 500 ng
mL
-1, respectively. The effect of variable glucose concen-
trations was investigated.
The peak potentials and currents associated with the
observed oxidation peaks were determined using
MATLAB
® software. Specifically, any oxidation peaks
present in the cyclic voltammograms were identified
and the electric potential range for the region of interest
corresponding to the oxidation peak defined (Figure 2).
Upper and lower boundaries corresponding to the
region of interest were determined by visual inspection
to identify the highest and lowest electric potentials
(voltages) corresponding to the width of the identified
oxidation peak. Linear regression and interpolation were
then used to fit a baseline bounded by the two points
corresponding to these upper and lower potentials. The
interpolated current values for the baseline were sub-
tracted from the original current values of the cyclic vol-
tammogram within the region of interest corresponding
to the oxidation peak. As a result, adjusted values for
the peak current were obtained.
In vitro microdialysis [22] was used in these experi-
ments to extract the released biochemical content from
the cell suspension, while high performance liquid chro-
matography (HPLC) with electrochemical detection was
Figure 2 Current-potential (i-V) curve acquired from the cyclic voltammetry of activated human WBCs suspended in PBS. An oxidation
peak is observed at ca. 400 mV.
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was released by the cells, as well as to quantify the
amount of serotonin released upon cell activation. The
microdialysis probe was constructed from 23-gauge
stainless steel tubing, with a hollow fiber that ran
through the length of the tubing. A small length of the
hollow fiber (approx 1.5 - 2.0 mm) was allowed to pro-
trude from the end of the stainless steel tube and
remained in contact with the surrounding solution.
Within the hollow fiber was vitreous silicate tubing.
This silicate tubing served as an inlet section for the
perfusing buffer, while the outlet section was housed in
the 23-G steel tubing. Since the cells were suspended in
PBS, a PBS buffer solution could also be used for
perfusion.
White blood cells were isolated as described pre-
viously. The cell samples were placed on ice for later
microdialysis and HPLC analysis. K562, BLCL and Jur-
kat cell lines were also analyzed. 1.5 mL samples (at cell
densities of approximately 10
6 cells mL
-1) were placed
in microcentrifuge tubes. The hollow fiber to be used
for microdialysis was allowed to equilibrate in fresh dis-
tilled water (dH2O) for a period of 30 minutes to one
hour. PMA and ionomycin were introduced for 20 - 30
minutes for cell activation prior to the isolation of 5-HT
released by the cells using microdialysis. Three samples
were collected from microdialysis of the cell suspensions
and controls (perfusion rate of 5 μLm i n
-1 for 2 min-
utes) in autosampler tubes. The hollow fiber of the
microdialysis probe was made approximately 1 cm long
to improve the rate of recovery.
For washing, the hollow fiber was placed in fresh dis-
tilled water (dH2O) and allowed to dialyze at a rate of
20 μLm i n
-1 for 2 minutes. It was then placed in fresh
dH2O for 3 minutes between samples to wash out any
residual 5-HT. 8.2 μL sample volumes were injected
into the HPLC by a FAMOS autosampler. Detection of
any 5-HT was determined electrochemically using an
Antec-Leyden Intro amperometric detector (Zoeter-
woude, The Netherlands).
Results
A. Measurement of Open Circuit Potential and Current
from BFC device
Average current densities between 0.9 and 1.6 μAc m
-2
(n = 3) and average open circuit potentials between 83
and 102 mV (n = 3) were measured when a proton
exchange membrane (PEM) fuel cell (PEMFC) contain-
ing WBCs isolated by RBC lysis was placed in series
with a 100 Ω resistor (Figure 3). There was significant
variation in the observed currents, with standard devia-
tions reaching as high +/- 61%. Over time; however the
standard deviations of the current density values across
the three WBC samples declined appreciably suggesting
that the system was gradually achieving stability. On
replacing the WBC suspension with a solution of the
activating agents (PMA and ionomycin) dissolved in
PBS, a decrease in the current density was observed
compared to the WBC suspension. In the case of this
control, a similar phenomenon was observed where the
standard deviation obtained from the three separate
experiments decreased over time. Again, this was attrib-
uted to the attainment of stability within the system.
The observation of small currents for the control is an
indication that the PMA and/or ionomycin have some
electrochemical activity. However, the results illustrated
in Figure 3 suggest that the white blood cells are also
transferring electrons to the electrode surface, contribut-
ing to the higher magnitude currents. The production of
metabolic products by the cells can be implicated, just
as bacterial cells in microbial fuel cells have been shown
to produce soluble metabolic products that are oxidized
at the fuel cell anode. A one-tailed student’s t-test of the
experimental and control data reveal a p value less than
0.05 (p = 1.1 × 10
-6) indicating that the current densities
recorded are significantly different.
The current output from PBMCs (isolated on a Ficoll-
Paque ™ gradient) within the same experimental setup
was also measured. The average current from the PBMC
was slightly lower than that recorded for the general WBC
population - which contains several other cell types,
including neutrophils in addition to the PBMCs (Figure 4).
A PEMFC containing PBS only (without activating agents)
at the anode did not produce any observable currents or
open circuit potentials (not shown). Introducing samples
of the PBS supernatant, used in the initial washing of both
the WBC and PBMC samples subsequent to isolation, into
the anode compartment of the PEMFC produced very
small to no currents (Figure 5). This further supports the
Figure 3 Currents produced from the PEM fuel cell following
introduction of activated WBCs and subsequent replacement
of the WBC suspension with PBS (n = 3). A significant decrease
in the current output occurs, indicating that the WBC suspension is
the primary contributor to the observed currents (p < 0.05).
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the cell isolation procedure, are primarily responsible for
the observed currents. Frequent measurements of pH
made during the course of all experiments also did not
reveal any significant changes across all anode solution
samples (pH maintained at 7.4 regardless of cell density,
cell activation or due to the presence of the activating
agents).
These results imply that within the general WBC
population, certain cells or the molecules released by
certain cells are electrochemically active at the elec-
trode surface. These can be attributable to the oxida-
tion of electrochemically active species that are either
released by the cells into the extracellular environment
(such as serotonin) or by redox active species that are
present in the cell membrane (such as flavohemopro-
teins of the NADPH oxidase complex, coenzyme A). In
o r d e rt ob ea b l et op r o d u c eac u r r e n tf r o mt h eB F C ,
protons must also be released by the cells into the
extracellular space. The increase in proton concentra-
tion in the anode compartment is important to create
a diffusion gradient, whereby the protons can traverse
the PEM to react with molecular oxygen to form water
at the cathode. Placing either PBS solution or deio-
nized water in both the anode and cathode compart-
ments did not produce any detectable currents and
were associated with open circuit potentials that were
less than 20 mV.
B. Cyclic Voltammetry
Cyclic voltammetry (CV) was utilized to investigate the
electrochemical activity of the isolated human white
blood cells. Cyclic voltammograms acquired from PMA
(5 ng mL
-1) and ionomycin (500 ng mL
-1) activated
human WBCs and PBMCs revealed oxidation peaks at
about 360 mV vs. SCE and peak currents up to 12 μA
for cell densities of 10
6 cells mL
-1 (Figure 2). Oxidation
peaks were not observed for any other cell type, i.e.
K562, Jurkat and BLCL cells. There was a noticeable
absence of a reduction peak in the voltammograms,
which normally implies that irreversible oxidation of the
species has occurred. Peaks were neither observed in the
absence of cells nor before activation of the cells with
PMA. The results of our experiments suggest that the
activated lymphocyte-monocyte mixture comprising the
PBMCs releases redox active species into the extracellu-
lar environment upon activation. Based on studies per-
formed by previous research groups (Table 1), it is likely
that the redox species responsible for the 360 mV oxida-
tion peak is 5-HT [23-26], although one paper cited
membrane bound proteins as the source of the oxida-
tion peak [27]. It has been suggested that 5-HT is
released from certain human leukocytes during inflam-
matory responses, particularly in response to allergens
during allergic reaction. In these studies, the oxidation
peak for 5-HT was normally detected at around 330 mV
vs. SCE, which is a slightly lower value than what we
have detected (360 mV), although the difference was not
significant. The absence of a reduction peak was often
reported in these studies, and has been attributed to the
Figure 4 Comparison of currents obtained from WBCs and
PBMCs.
Figure 5 Comparison of open circuit potentials (bars) and
currents (lines) obtained from the supernatant (PBS used to
wash the cells during the initial Ficoll isolation procedure) for
both the WBCs (top) and PBMCs (bottom). Relatively small
currents to no currents were observed for the PEM fuel cell
apparatus.
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xyindoleacetic acid (5-HIAA) [26].
The oxidation peaks obtained from the cell suspen-
sions were barely discernable against the background
currents, as the total area bounded by each CV curve
was very large by comparison to the area bounded by
the oxidation peaks within the 350 mV to 400 mV
range (Figure 2). The large background currents are a
direct consequence of two factors, namely the scan rate
(set at 100 mV s
-1) and the large surface area of the car-
bon fiber electrodes (PRF Composite Materials, Dorset,
England). Greater surface area of the electrode leads to
greater capacitance. The relationship between the scan
rate, capacitance and voltammetric current can be
expressed by the following equation:
i = υCd

1 − exp

−t/RsCd

(1)
where i is current, v is the scan rate, Cd is the capaci-
tance of the electrode, t is time and Rs is solution resis-
tance [28]. The peak current for an irreversible reaction
is described by the following equation:
ip=

2.99 x 105
α1/2n3/2AD 0
1/2C0
∗υ1/2 (2)
where ip is peak current, a is the electron transfer
coefficient, n is the number of electrons transferred, A is
surface area, Do is the diffusion coefficient, Co* is the
concentration of the species in the bulk solution and v
is the scan rate [28].
The 30 mV difference between the peak potentials
reported in the literature (330 mV) and our own (360
mV) is not interpreted to be meaningful. 30 mV may
not be significant, since scan conditions and electrode
surface features can significantly impact peak potential.
Figure 6 shows that the magnitude of the oxidation
peak current increases with cell density, further verifying
the relationship between the cells and the electrochemi-
cal activity. The relationship between cell density and
peak current in Figure 6 appears to be nonlinear. How-
ever, this may only be an apparent nonlinearity as
variability in how strongly cells from different subjects
respond to the PMA activation agent can occur. As a
consequence, this would affect how much serotonin is
ultimately produced.
It is well known that several types of cells contain pro-
tein complexes in their cell membranes that function as
electron transport chains. The NADPH oxidase com-
plex, for example, comprises structures within the
plasma membrane that upon association in an activated
state transfer electrons between the pentose phosphate
pathway of glucose metabolism and extracellular oxygen.
Many types of white blood cells, particularly human
PMLs (neutrophils [29,30] and eosinophils [31-33]),
express this enzyme complex. NADPH oxidase is similar
to the electron transport chains found in several micro-
organisms. Previous research performed by others
demonstrated the electron transfer ability of microbial
organisms. It is known that these microorganisms can
transfer electrons to electrodes by various mechanisms,
including: i) the use of artificial electron mediators (elec-
tronophores) such as neutral red; ii) using mediators
produced by the microorganisms themselves; iii) direct
Table 1 Cyclic voltammetry studies of white blood cells
Reference Cells Working
electrode
Ep Ip Electroactive
species
Nakamura et
al. (1991) [23]
Human leucocytes Basal plane
pyrolytic
graphite
0.33 V and 0.68 V (leucocytes)
and 0.68 V (erythrocytes)
0.36-0.58 μA per 10
6
cells for Ep = 0.33 V
Serotonin (0.29-0.34
V)
CoA (0.65-0.74 V for
microorganisms)
Matsunaga et
al. (1989) [24]
Rat basophilic leukemia cells (RBL-
1) and mouse lymphocytes
Basal plane
pyrolytic
graphite
0.34 V and 0.68 V (RBL-1)
0.65 V (mouse lymphocytes)
0.76 μA per 10
5 cells
for Ep = 0.34 V
Serotonin (0.29-0.34
V)
CoA (0.65-0.74 V for
microorganisms)
Ci et al. (1998)
[27]
White rabbit leukocytes and
erythrocytes
Graphite 0.32 V (leukocytes)
0.73 V (erythrocytes)
1 μA per 10
5 cells for
Ep = 0.32 V
Membrane-bound
proteins?
All measurements were made in PBS with a saturated calomel electrode (SCE) as the reference electrode.
Figure 6 Variation in the amplitude of the oxidation peak
current is plotted with PBMC density. Increasing the cell density
is associated with an apparent non-linear increase in the oxidation
peak.
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Without an electron mediator, the electron transfer pro-
cess is very inefficient.
C. Microdialysis and HPLC
The HPLC results confirmed that serotonin was in fact
released from PMA/ionomycin activated white blood
cells, specifically PBMCs (Figure 7). A 5-HT concentra-
tion of approximately 291 nM (+/- 34 nM) was calcu-
lated to be associated with the activation of PBMCs at a
cell density of 10
6 cells mL
-1. In contrast, no 5-HT was
detected from the K562, BLCL or Jurkat cells. The
r e s u l t so ft h i se x p e r i m e n ti n d icate that increased extra-
cellular concentrations of serotonin, from the activated
PBMCs, are directly associated with the oxidation peaks
observed in the i-V curves obtained using cyclic voltam-
metry. The fact that none of the cell lines were asso-
ciated with oxidation peaks suggests that these cells do
not release serotonin. This was verified by the absence
of corresponding serotonin peaks in the HPLC chroma-
tograms of these cells (not shown). These experiments
highlight that important differences do exist between
isolated human white blood cells and their correspond-
ing cell lines cultured in vitro.
Discussion
Electron transport, pervasive in the plasma membranes
of microbes, is generally not observed across the extra-
cellular membranes of eukaryotic cells. The presence of
an electron transport chain in the extracellular mem-
branes of microbes provides a likelihood of electron tun-
neling occurring between the membrane-bound species
and the electrode surface. In eukaryotic cells, electron
transport is a process that is normally relegated to the
membranes of intracellular mitochondria. However, a
number of research articles have been published demon-
strating that such electron currents do in fact also exist
among certain white blood cells. Schrenzel et al. (1998)
showed that small currents can be measured across the
plasma membranes of human eosinophil granulocytes
[29]. The experiments were performed based on the
hypothesis that the membrane associated enzyme
NADPH oxidase, found in blood phagocytes (e.g. neu-
trophils and eosinophils), generates superoxide through
electron transfer from NADPH to extracellular oxygen.
The magnitudes of the currents recorded across the
extracellular membranes were on the order of 10 to 20
pA per cell in these studies.
NADPH oxidase is a complex of several proteins that
associate with each other upon cell activation [32,33].
Activation in vitro is normally achieved by application
of a phorbol ester, phorbol-12-myristate-13-acetate
(PMA) [29,30,33]. Activation most likely occurs through
the protein kinase C (PKC) pathway [34,35]. The
enzyme complex and its analogs have also increasingly
been found in a variety of different cell types including
microglia [36], vascular smooth muscle [37], hemato-
poietic stem cells [38], and endothelial cells [39]. The
presence of an electron transport chain in the plasma
membranes of white blood cells means that it may be
possible to “hijack” these high energy electrons in order
to divert them to a nearby electrode. Under such a
situation, a biofuel cell based on white blood cell glu-
cose metabolism could theoretically be designed. The
electrical interactions between the cells and the elec-
trode surface become important for such a direct elec-
tron transfer process to take place.
The idea of using electrons derived from NADPH oxi-
dase to power a biofuel cell was first proposed by Justin
and colleagues [1-3,40-45] and then more recently by
Figure 7 Release of serotonin from activated WBCs and more specifically, PBMCs. Following the microdialysis ("dial”) of 5-HT (500 nM),
PBS, PBMCs and activated PBMCs, 5-HT was determined using HPLC. A recovery estimate of 9% (+/- 1%) was determined for the microdialysis
probe (as calculated from 5-HT standard and dial 5-HT in A). Based on this estimate, a 5-HT concentration of approximately 291 nM (+/- 34 nM)
was calculated to be associated with the activation of PBMCs at a cell density of 10
6 cells mL
-1 (B). 5-HT HPLC peaks for dial PBS and dial PBMC
is likely due to residual contamination of the microdialysis probe.
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Justin and colleagues, including this one, human white
blood cells were isolated directly from whole human
blood. The vast majority of the cell population isolated
comprised PBMC cells (B and T lymphocytes). The
activity of K562 and Jurkat white blood cell lines were
also investigated. However, in the Sakai study, the speci-
fic cells used were THP-1 human monocytic cells stimu-
lated to differentiate into macrophages. The Sakai study
demonstrated that the current output from a BFC incor-
porating macrophages at the anode could be disrupted
by application of NADPH oxidase inhibitors such as
diphenylene iodinium (DPI). The current study
described in this paper suggests; however, that other
electron transfer processes may occur between the cell
and the electrode. As demonstrated in this work, seroto-
nin released from activated white blood cells is a likely
mediator for electron transfer between the cells and the
electrode. Despite confirmation of this by employing
electrochemical techniques such as cyclic voltammetry
and HPLC for validation, it is difficult to dispute the
possibility that NADPH oxidase is also active. One of
the reasons that our studies did not reveal CV redox
peaks due to NADPH oxidase may have been due to
NADPH oxidase not being as active among PBMCs
compared to macrophages such as neutrophils and eosi-
nophils. Only very low levels of macrophages would
normally be isolated from healthy individuals, as was the
case in our study - a necessary requirement for Institu-
tional Review Board (IRB) compliance. Therefore, the
effect of NADPH oxidase activity specifically on the bio-
fuel cell currents would not have been as predominant
as culturing differentiated macrophages onto electrodes
as performed by Sakai and colleagues. It is surprising
that in the work by Sakai and colleagues that a larger
background current associated with serotonin was not
observed. This suggests that serotonin may not be pro-
duced by the differentiated monocytes, unlike the phe-
nomenon of release demonstrated by the cells used in
our studies. Vastly different mechanisms of electron
transfer for the specific white blood cells used in the
two studies are very likely.
T h ei d e ao fh a r v e s t i n ge l e c t r o n sf r o mw h o l ec e l l si s
not a new one. Previous studies performed by other
researchers on microbial fuel cells suggested that under
normal conditions, it is very difficult to achieve direct
electron transfer between the cell membrane compo-
nents of the microbes and an interfacing electrode [14].
An important reason for this is the fact that the redox
active groups are generally embedded within integral
membrane proteins, resulting in a significant energy bar-
rier that increases with increased distance between elec-
tron donor and receptor pairs. Electron tunneling
between the membrane components and the electrode
surface is further discouraged because of the thermody-
namically unfavorable conditions surrounding the move-
ment of free electrons through an aqueous solution. In
order to overcome this challenge, many microbial fuel
cell researchers employed electron mediators that were
capable of shuttling electrons between the membrane-
bound redox active components of the microbes and
the electrode. Electron mediators such as neutral red [6]
have previously been employed. The use of these elec-
tron mediators significantly increased the efficiency in
electron transfer and thus the current output of the
microbial fuel cells.
A future goal in continuing the work described in this
paper would be to explore means of enhancing the elec-
tron transfer efficiency of human leukocytes for enhan-
cing current and power densities in implantable biofuel
cell applications.
Conclusions
In this study, we proposed the development of a novel
biological fuel cell that can utilize the body’so w n
resources to generate electricity, through specific elec-
trochemical interactions between cells and electrodes in
close proximity. The motivation of this study is to
develop a BFC that can be used to power implantable
medical devices, including micro- and nano- biosensors
f o re i t h e rt h e r a p e u t i co rp h ysiological monitoring pur-
poses. The study seeks to demonstrate that electron
transfer between human white blood cells and an inter-
facing electrode can occur through any or all of three
possible mechanisms: 1) direct electron transfer through
membrane bound redox species (such as the flavocyto-
chrome of NADPH oxidase); 2) indirect electron trans-
fer through exocytosed non-metabolic biochemical
species (e.g. serotonin); and 3) indirect electron transfer
through exocytosed metabolically relevant biochemical
species. Our results indicate that activated white blood
cells can generate small electrical currents when intro-
duced into the anode compartment of a proton
exchange membrane fuel cell, with ferricyanide in the
cathode compartment. Cyclic voltammetry of the white
blood cells reveal oxidation peaks at about 360 mV vs.
SCE. Peaks at this potential have been attributed to ser-
otonin release. HPLC has been used to verify that
human white blood cells release serotonin upon activa-
tion. Various white blood cell lines do not release sero-
tonin, indicating that the isolated cells may uptake
serotonin from the blood stream rather than metabolize
it themselves.
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